Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06063_nanopub.RAVF6hS3d_-bSwVGaQVIicML00spybNjJJR3ujMe5NCIQ#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB06063 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06063 label "CAM-2029 [drugbank:DB06063]" assertion.
- drugbank:DB06063 seeAlso DB06063 assertion.
- drugbank:DB06063 description "CAM2029 is a new ready-to-use, long-acting octreotide formulation being developed for the long-term treatment of acromegaly, carcinoid syndrome and vasoactive intestinal peptide (VIP)-producing tumours. CAM2029 was found to provide long-acting release of octreotide resulting in a statistically significant suppression of a clinical biomarker insulin-like growth factor 1 (IGF-1) over the target one-month therapeutic period." assertion.
- drugbank:DB06063 identifier "drugbank:DB06063" assertion.
- drugbank:DB06063 title "CAM-2029" assertion.
- drugbank:DB06063 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB06063 drugbank_vocabulary:drugbank-id "DB06063" assertion.
- drugbank:DB06063 bio2rdf_vocabulary:x-identifiers.org DB06063 assertion.
- drugbank:DB06063 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06063" assertion.
- drugbank:DB06063 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06063 bio2rdf_vocabulary:identifier "DB06063" assertion.